Feature Channels: Respiratory Diseases and Disorders

Filters close
Newswise: Electronic Pneumonia Decision Support Helps Reduce Mortality by 38% in Community Hospitals, New Study Finds
Released: 9-Mar-2022 8:00 AM EST
Electronic Pneumonia Decision Support Helps Reduce Mortality by 38% in Community Hospitals, New Study Finds
Intermountain Healthcare

A real-time electronic decision support system helped clinicians at community hospitals provide best practice care for emergency department patients with pneumonia, resulting in decreased intensive care unit admission, more appropriate antibiotic use, and 38% lower overall mortality according to a new study by researchers at Intermountain Healthcare in Salt Lake City.

Released: 7-Mar-2022 3:30 PM EST
Providing Care to Refugees, Others Affected by Violence in Ukraine Must Be a Global Priority: American Thoracic Society
American Thoracic Society (ATS)

Today, the American Thoracic Society joined the chorus of voices worldwide condemning the violence in Ukraine.

Newswise: Nanoparticle reduces skin and lung scarring for scleroderma, mouse study finds
Released: 7-Mar-2022 10:40 AM EST
Nanoparticle reduces skin and lung scarring for scleroderma, mouse study finds
Michigan Medicine - University of Michigan

Researchers found a unique immune cell plays a key role in the chronic inflammation and scarring in the lungs and skin of people with scleroderma, or systemic sclerosis. After injecting mice with biodegradable PLG nanoparticles, which are used in medical sutures, researchers found that the nanoparticles specifically targeted these inflammatory cells and prevented skin and lung fibrosis. Researchers say it's a promising step towards targeted treatment for patients with early scleroderma.

28-Feb-2022 1:55 PM EST
First Potential Immunization Against RSV for Healthy Infants Found Highly Effective in Phase 3 Trial
Ann and Robert H. Lurie Children's Hospital of Chicago

Nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomised, placebo-controlled Phase 3 clinical trial. It is the first potential immunization against RSV in the general infant population, with a single dose providing safe protection across the entire RSV season. Results were published in the New England Journal of Medicine.

Released: 2-Mar-2022 8:00 AM EST
Standard for Pulmonary Function Tests Gets an Update
American Thoracic Society (ATS)

In the latest update to the pulmonary function tests technical standard series, the American Thoracic Society and European Respiratory Society address the uncertainty around the interpretation of the tests which are essential in determining the extent of respiratory dysfunction. The update was recently published in the European Respiratory Journal ahead of a planned webinar series by the ATS.

Released: 1-Mar-2022 3:45 PM EST
Investigating The Effects of Critical Illness in Early Childhood On Neurocognitive Outcomes
University of Pennsylvania School of Nursing

Approximately 23,700 children in the U.S. undergo invasive mechanical ventilation for acute respiratory failure annually. Although most survive, little is known if they have worse long-term neurocognitive function than children who do not undergo such procedures. There are concerns about neurotoxic effects of critical illness and its treatment on the developing brain. Therefore, infants and young children may be uniquely susceptible to adverse neurocognitive outcomes after invasive mechanical ventilation.

Released: 1-Mar-2022 12:45 PM EST
Face masks play a crucial role, new COVID research confirms
Chalmers University of Technology

An international research team from universities including Chalmers University of Technology, Sweden, the University of Padua and the University of Udine in Italy, and the University of Vienna, Austria, has developed a new theoretical model to better assess the risks of spreading viruses such as Covid-19 – with and without a face mask.

Newswise: Analysis Yields In-depth Insights Into Illness Trajectory of Hospitalized COVID-19 Patients
24-Feb-2022 12:45 PM EST
Analysis Yields In-depth Insights Into Illness Trajectory of Hospitalized COVID-19 Patients
American Association of Critical-Care Nurses (AACN)

An analysis of data from 1,480 COVID-19 patients hospitalized in March 2020 at 57 U.S. hospitals is one of the few studies conducted in diverse, multicenter patient populations that describes patients’ illness trajectory, patterns of organ failure, therapies and clinical outcomes.

28-Feb-2022 7:00 AM EST
Vapers Exhale from Nose More Often than Cigarette Smokers
NYU Langone Health

E-cigarette vapers and hookah smokers are more than twice as likely to exhale particles through their nose compared with cigarette smokers, who favor exhaling the emissions from their mouth, a new study shows. The finding makes it plausible that the former group is at risk for inflammation and cancers of the nose, sinuses, and throat, conditions seen less often in cigarette smokers, according to the study authors.

24-Feb-2022 3:05 PM EST
Antibiotic doesn’t prevent future wheezing in babies hospitalized with RSV
Washington University in St. Louis

Antibiotics provide no benefit in preventing future recurrent wheezing in babies hospitalized with respiratory syncytial virus (RSV), according to a new study led by Washington University School of Medicine in St. Louis. And there is some evidence that antibiotics may make wheezing worse.

Released: 22-Feb-2022 9:05 AM EST
Using Telehealth to Support Children on Home Mechanical Ventilation
Children's Hospital Los Angeles

Virtual visits allow providers to assess home setup and safety—and help families breathe easier. An innovative telehealth program at Children’s Hospital Los Angeles is offering an extra layer of support to a particularly fragile patient population: children on home mechanical ventilation.Through the program, which began in February 2020, all families have a virtual video visit with their pulmonologist and nurse care manager within 48 hours of their child being newly discharged from the hospital on a ventilator.

17-Feb-2022 3:35 PM EST
The Latest Research News in Cardiovascular Health
Newswise

The Latest Research News in Cardiovascular Health

Newswise: Loyola University Chicago Stritch School of Medicine and Loyola Medicine Appoint Internationally-Recognized Expert in Lung Disease to Lead Department of Medicine
Released: 21-Feb-2022 6:05 PM EST
Loyola University Chicago Stritch School of Medicine and Loyola Medicine Appoint Internationally-Recognized Expert in Lung Disease to Lead Department of Medicine
Loyola Medicine

Loyola University Chicago Stritch School of Medicine and Loyola Medicine, its academic medical center partner and a member of Trinity Health, announce the appointment of Marilyn Glassberg Csete, MD, as chair of the department of medicine, effective July 1, 2022.

Released: 16-Feb-2022 8:00 AM EST
Save the Date! Cover ATS 2022 in San Francisco!
American Thoracic Society (ATS)

After two years of virtual conferences, the ATS 2022 International Conference will be live and in-person. San Francisco will play host to the largest gathering of scientists and clinicians in pulmonary, critical care, and sleep medicine.

Newswise: Starting antiretroviral therapy early essential to battling not one, but two killers
Released: 15-Feb-2022 4:05 PM EST
Starting antiretroviral therapy early essential to battling not one, but two killers
Texas Biomedical Research Institute

Medication against the nonhuman primate version of HIV given two weeks after infection helped keep tuberculosis in check.

Released: 15-Feb-2022 8:05 AM EST
If you have COVID, it’s rare you won’t have symptoms
Uniformed Services University of the Health Sciences (USU)

Asymptomatic COVID infection in generally healthy unvaccinated adults is likely much less common than previously reported, according to a new study published Feb. 14 in Open Forum Infectious Diseases by researchers at the Uniformed Services University of the Health Sciences (USU).

Released: 14-Feb-2022 4:05 PM EST
Enhanced external counterpulsation offers potential treatment option for long COVID patients
American College of Cardiology (ACC)

In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest discomfort, after undergoing 15-35 hours of enhanced external counterpulsation (EECP) therapy.



close
2.46959